FINANCIALS

MYGN Myriad Genetics Inc 899923

Income Statement
Revenue	mygn-20241231	837,600,000
Net Income	mygn-20241231	-127,300,000
Profit Margin		-15.2%

Balance Sheet
Current Assets	298,000,000
Assets	1,027,600,000
Current Liabilities	164,100,000
Liabilities	326,500,000
Equity	701,100,000
Shares Out	90,820,000

Cash Flow Statement
Operating Cash Flow	-8,700,000
Investing Cash Flow	-11,900,000

Market Analysis
Market Cap	2,587,018,010
Price	9.90
BVPS	7.72
PB	1.29
EPS	-1.80
PS	0.77
FCF	-20,600,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view MYGN documents filed with the SEC.

MYGN Filings Clear

View A List of Tickers